Detailed Explanation
Risk-based monitoring represents a fundamental shift in how sponsors approach clinical trial oversight, moving from traditional approaches emphasizing uniform, comprehensive on-site verification toward strategic allocation of monitoring resources based on identified risks. This approach, explicitly endorsed by ICH E6(R3), recognizes that not all data, sites, and processes carry equal risk to participant safety and data integrity, and that monitoring resources should be concentrated where they can have the greatest impact.